Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110305025B details a green photocatalytic method for benzylamine synthesis using Eosin Y and water, offering significant cost and safety advantages for pharmaceutical intermediates.
Novel synthesis method for azacycle-derived polyarylmethane antitumor compounds offering mild conditions and high cytotoxic activity for pharmaceutical supply chains.
Patent CN111978265B reveals a novel FeCl3-catalyzed route for 5-trifluoromethyl-1,2,4-triazoles, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN108727323B details a green NHC-catalyzed route for trifluoromethyl homoisoflavones, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN108620130B reveals a stable o-carborane iridium catalyst for green imine synthesis, offering significant cost reduction and supply chain reliability for pharma manufacturing.
Ruthenium-catalyzed preparation method offers high yield and industrial scalability for pharmaceutical intermediates supply chain optimization and significant cost reduction benefits.
Patent CN110452150A reveals a novel chiral phosphoric acid catalyzed synthesis. Offers mild conditions and high enantioselectivity for reliable supply chain integration.
Patent CN102766092A reveals a mild, high-enantioselective route to tetrahydroquinoline derivatives using chiral spiro phosphoric acid, offering significant cost reduction in API manufacturing.
Patent CN113307790B reveals a metal-free oxidative cyclization for high-purity triazole intermediates, offering significant cost reduction and scalable manufacturing for pharmaceutical applications.
Patent CN116462636B reveals green visible light synthesis for quinoxalinone derivatives. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel glucose-based route for 3-trifluoromethyl-1,2,4-triazoles offers mild conditions and high efficiency for reliable pharmaceutical intermediate supply chains.
Patent CN112321553A reveals a catalyst-free visible light method for 3-difluoromethyl coumarins, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel rare earth catalyzed decarbonylation hydroamination process offers mild conditions and high purity for pharmaceutical intermediate manufacturing supply chain optimization.
Patent CN108558734A details copper-catalyzed indole synthesis offering cost reduction and supply reliability for pharmaceutical intermediate manufacturing partners.
Patent CN111217847B reveals novel thiosilane ligands enabling high-yield aryl boronation with superior purification and industrial scalability for pharma intermediates.
Patent CN109912606B reveals a novel metal-free synthesis for pyrimidoindazoles. Discover cost-effective, scalable manufacturing for kinase inhibitor intermediates.
Novel chiral phosphoric acid catalysis enables high-yield indolocyclopentanes production with enhanced supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113735756A details a high-yield Rh-catalyzed method for chiral 3,3-disubstituted isoindolinones, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel synthesis method for N-N axis chiral compounds offers high enantioselectivity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Patent CN112194608A details a visible-light promoted synthesis method offering high yields and mild conditions for pharmaceutical intermediates.